Reinsurance Group of America (RGA) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
7 Jan, 2026Strategic Transaction Overview
RGA will reinsure $32 billion of diversified life insurance products from Equitable, covering 75% of in-force liabilities and expanding into product development, underwriting outsourcing, and asset management.
The transaction is positioned as mutually beneficial, supporting client strategy, delivering attractive returns within target ranges, and reinforcing RGA's expertise in biometric risk and global liability origination.
The deal is expected to close in mid-2025, pending regulatory approvals.
Equitable will retain direct policyholder administration, minimizing operational risks and aligning interests.
The transaction highlights RGA’s ability to execute large in-force deals and provide creative, technical solutions.
Financial Impact and Capital Deployment
RGA will deploy $1.5 billion of capital, funded through excess capital and potential debt, with $800 million of deployable capital remaining post-transaction.
Projected to contribute $70 million in adjusted operating income before tax in 2025, $160–$170 million in 2026, and about $200 million annually after asset repositioning.
Return on equity is expected within the 13%-15% target range, with a capital structure of 70% equity and 30% debt.
The transaction is consistent with 8%-10% CAGR run-rate guidance and is expected to meaningfully boost adjusted operating EPS.
RGA expects to maintain strong capital and leverage positions, with no equity capital raise anticipated.
Risk Profile and Business Mix
The reinsured block features a diversified mix of life products, with modest exposure to secondary guarantees and limited income volatility from equity market exposure.
93% of reserve liabilities have low or very low policyholder behavior risk to interest rate changes.
The transaction is weighted toward insurance risks, with lower policyholder behavior risk and an investment strategy aligned with RGA's credit risk profile.
Cedant retains direct policy administration, minimizing operational risks.
Asset repositioning from the transaction is expected to complete in about 12 months, with full income contribution realized in the second year.
Latest events from Reinsurance Group of America
- Record earnings, strong premium growth, and new share repurchase authorization.RGA
Q4 20256 Feb 2026 - Innovation, global scale, and disciplined capital management drive strong growth and returns.RGA
Investor Day 20243 Feb 2026 - Adjusted operating EPS hit $5.48, ROE 15.3%, and $307M deployed into in-force transactions.RGA
Q2 20242 Feb 2026 - Record adjusted operating income and ROE, with strong premium growth and capital deployment.RGA
Q3 202417 Jan 2026 - Record operating income, capital deployment, and higher ROE targets highlight strong growth.RGA
Q4 20248 Jan 2026 - Board recommends approval of all proposals amid record results and strong governance.RGA
Proxy Filing1 Dec 2025 - Q1 2025 EPS $5.66, ROE 15%, net income $288M; $32B reinsurance deal pending.RGA
Q1 202529 Nov 2025 - Record EPS, robust capital deployment, and a $12B reinsurance deal drive strong results.RGA
Q3 20251 Nov 2025 - Q2 2025 saw strong capital and premium growth despite claims volatility and a major reinsurance deal.RGA
Q2 202531 Oct 2025